Old economy stocks could be next year’s story: Jonathan Schiessl
It is probably worthwhile having a barbell approach in the pharma sector with mainly largecap names and maybe one or two smaller ones as well, says the Global Investment Strategist. How are you looking at the overall sentiment for the emerging markets and in particular for India? The mid and the smallcaps too have been … Read more